Cilazapril plus hydrochlorothiazide: Improved efficacy without reduced safety in mild to moderate hypertension; a double-blind placebo-controlled multicenter study of factorial design

Cardiology (Switzerland)

Volumn 85, Issue 5, 1994, Pages 311-322

  Pordy, Robert C ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Antihypertensive agents; Cilazapril; Diuretics; Hypertension; Thiazide

Indexed keywords

ANTIHYPERTENSIVE AGENT; CILAZAPRIL; CILAZAPRIL PLUS HYDROCHLOROTHIAZIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; POTASSIUM; THIAZIDE DIURETIC AGENT; URIC ACID;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FATIGUE; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHINITIS; SOMNOLENCE; URIC ACID BLOOD LEVEL; VERTIGO;

ADMINISTRATION, ORAL; ADULT; AGED; BLOOD PRESSURE; CILAZAPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; POTASSIUM; SEVERITY OF ILLNESS INDEX; URIC ACID;

EID: 0028151246     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000176704     Document Type: Article

References (20)

1. Weinberger MH: Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension. Br J Clin Pharmacol 1982;14:127S-131S.
2. Vidt DG (for the Multiclinic Study Group): A controlled multiclinic study to compare the antihypertensive effects of MK-421, hydrochlorothiazide and MK-421 combined with hydrochlorothiazide in patients with mild to moderate essential hypertension. J Hypertens 1984; 2:81-88.
3. Vlasses PH, Rotmensch HH, et al: Comparative antihypertensive effects of enalapril maleate and hydrochlorothiazide. alone and in combination. J Clin Pharmacol 1983;23:227-233.
4. Creisson C, Baulac L, et al: Captopril/hydrochlorothiazide combination in elderly patients with mildmoderate hypertension. A double-blind, randomized, placebo-controlled study. Postgrad Med J 1986; 62:139-141.
5. Costa FV, Borghi C, et al: Differing doses of captopril and hydrochlorothiazide in the treatment of hypertension: Long term effects on metabolic values and intracellular electrolytes. J Cardiovasc Pharmacol 1985;7:s70-s76.
6. Weinberger MH: Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild to moderate hypertensive patients. J Cardiovasc Pharmacol 1985;7:s52-s55.
7. SAS (Statistical Analysis System) User’s Guide. Statistics, version 5 edition. Cary, SAS Institute, 1990, pp 433-506.
8. Snappin S: Evaluating the efficacy of a combination therapy. Stat Med 1987;6:657-665.
9. Holm S: A simple sequentially rejective multiple test procedure. Scand J Stat 1979;G:65-70.
10. Martina B, Weinbacher M, et al: Efficacy and tolerability of cilazapril 5 mg + hydrochlorthiazide 12.5 mg in mild to moderate hypertension. Results of 24 hour ambulatory blood pressure monitoring. J Cardiovasc Pharmacol 1994;24(suppl 3):S89-S92.
11. Beiz GG, Lang H, et al: Cilazapril bei essentieller Hypertonie. Eine placebokontrollierte Doppelblindstudie zur Dosisfindung. Med Klin 1986;81:524-525.
12. White WB, McCabe EJ, et al: The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure. Clin Pharmacol Ther 1988;44:173-178.
13. Ferguson RK, Stanley HR, et al: Once-daily cilazapril versus propranolol in mild to moderate essential hypertension. Chest 1988; 94(suppl):66S.
14. Beiz GG, Breithaupt C, et al: Can a combination of ACE-inhibitor and beta-blocker be successfully used for the treatment of hypertension. Clin Pharmacol Ther 1989;45:142.
15. Hoverman RJ, Jones RW, et al: Efficacy and safety of cilazapril in elderly patients with essential hypertension. A multicenter study. Am J Med 1989;87/6B:6B-33S-6B-36S.
16. Morgan TO (for the Multicenter Study Group): Efficacy of cilazapril compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension. Am J Med 1989;87/6B:6B-37S-6B-41S.
17. Sanchez RA, Traballi CA, et al: Long-term evaluation of cilazapril in severe hypertension. Assessment of left ventricular and renal function. Am J Med 1989;87/6B:6B- 56S-6B-60S.
18. Kobrin I, Guntzel P, et al: Antihypertensive duration of action of cilazapril in patients with mild to moderate essential hypertension. Drugs 1991;41(suppl 1):31-36.
19. Bourassa MG: Summary and closing remarks. Drugs 1991;41 (suppl 1):68-69.
20. Deget F, Brogden RN: Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease. Drugs 1991;41:799-820.